Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $19.9200 (-1.07%) ($19.9200 - $19.9200) on Mon. Feb. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 36 | Latest Price | $19.9200(-1.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.7% a day on average for past five trading days. | Weekly Trend | FOLD declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(53%) IWO(49%) XBI(48%) IWM(46%) IWC(44%) | Factors Impacting FOLD price | FOLD will decline at least -1.445% in a week (0% probabilities). VIXM(-28%) VXX(-13%) UUP(-11%) UNG(-6%) USO(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $20.67 | 5 Day Moving Average | $20.08(-0.8%) | 10 Day Moving Average | $19.68(1.22%) | 20 Day Moving Average | $20.67(-3.63%) | To recent high | -20% | To recent low | 5.3% | Market Cap | $5.144b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |